Viatris (VTRS) Interest Coverage Ratio Growth (3y) (2022 - 2026)
Viatris (VTRS) Interest Coverage Ratio Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.70 Bn | 30.76 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 27.73 Bn | 23.67 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | -28.01% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.18 Bn | 18.37 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 41.72% |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 182.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.31% |
| Dec 31, 2025 | -5.59% |
| Sep 30, 2025 | 76.19% |
| Jun 30, 2025 | -10.31% |
| Mar 31, 2025 | -108.58% |
| Dec 31, 2024 | -41.89% |
| Sep 30, 2024 | 113.31% |
| Jun 30, 2024 | -326.70% |
| Mar 31, 2024 | 43.77% |
| Dec 31, 2023 | 19.14% |
| Sep 30, 2023 | 0.49% |
| Jun 30, 2023 | 36.44% |
| Mar 31, 2023 | -48.61% |
| Dec 31, 2022 | -45.08% |